Boehringer Avoids Pradaxa Trial, Board Chair Deposition With $650 Mil. Settlement
This article was originally published in The Pink Sheet Daily
Executive Summary
Settlement expected to resolve approximately 4,000 Pradaxa personal injury claims.
You may also be interested in...
After 5-Year Winning Streak, Xarelto Makers Settle Personal Injury Suits
Bayer and Johnson & Johnson agree to resolve approximately 25,000 claims in federal and state courts for $775m, almost 13% of Xarelto's 2018 sales.
Strong Xarelto Label Warnings Lead To Another Jury Win For Bayer And Janssen
Philadelphia jurors find that warnings of bleeding risk with Xarelto are adequate, giving companies 5-0 litigation score; sixth trial in June.
Xarelto Liability Suit: Is Label 'Silent' About Increased Bleeding Risk?
Even after multiple bellweather wins, Janssen and Bayer still face claims they did not warn doctors about concomitant use with Plavix and aspirin; as case begins in Philadelphia, plaintiff's attorney tells jury the firms were 'silent,' while defense points to doctors' testimony that a different warning would not have changed their prescribing.